Select Publications
Books
2018, Preface to the First Edition, http://dx.doi.org/10.1016/B978-0-12-804182-6.00049-6
,2018, Preface to the Second Edition, http://dx.doi.org/10.1016/B978-0-12-804182-6.00047-2
,2017, Genetics of Bone Biology and Skeletal Disease: Second Edition
,2013, Genetics of Bone Biology and Skeletal Disease, http://dx.doi.org/10.1016/C2010-0-67110-0
,Book Chapters
2018, 'Fracture liaison service', in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Wiley, pp. 405 - 411, http://dx.doi.org/10.1002/9781119266594.ch51
,2018, 'GENETICS OF BONE BIOLOGY AND SKELETAL DISEASE SECOND EDITION Preface to the Second Edition', in Thakker RV; Whyte MP; Eisman JA; Igarashi T (ed.), GENETICS OF BONE BIOLOGY AND SKELETAL DISEASE, 2ND EDITION, ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD, pp. XV - XVI, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000541745500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Chapter 68 Vitamin D and Osteoporosis', in Vitamin D, Elsevier, pp. 203 - 220, http://dx.doi.org/10.1016/b978-0-12-809963-6.00068-7
,2018, 'Chapter 9 Pharmacogenetics and Pharmacogenomics of Osteoporosis: Personalized Medicine Outlook', in Genetics of Bone Biology and Skeletal Disease, Elsevier, pp. 139 - 157, http://dx.doi.org/10.1016/b978-0-12-804182-6.00009-5
,2018, 'Preface to the First Edition', in Genetics of Bone Biology and Skeletal Disease, Elsevier, pp. xvii - xviii, http://dx.doi.org/10.1016/b978-0-12-804182-6.00049-6
,2018, 'Preface to the Second Edition', in Genetics of Bone Biology and Skeletal Disease, Elsevier, pp. xv - xvi, http://dx.doi.org/10.1016/b978-0-12-804182-6.00047-2
,2017, 'Pharmacogenetics and Pharmacogenomics of Osteoporosis: Personalized Medicine Outlook', in Genetics of Bone Biology and Skeletal Disease: Second Edition, pp. 139 - 157, http://dx.doi.org/10.1016/B978-0-12-804182-6.00009-5
,2017, 'Vitamin D and Osteoporosis', in Vitamin D: Health, Disease and Therapeutics, Fourth Edition: Volume 2, pp. 203 - 220, http://dx.doi.org/10.1016/B978-0-12-809963-6.00068-7
,2013, 'Chapter 11 Pharmacogenetics and Pharmacogenomics of Osteoporosis Personalized Medicine Outlook', in Genetics of Bone Biology and Skeletal Disease, Elsevier, pp. 151 - 167, http://dx.doi.org/10.1016/b978-0-12-387829-8.00011-1
,2013, 'Pharmacogenetics and Pharmacogenomics of Osteoporosis: Personalized Medicine Outlook', in Thakker RV; Whyte MP; Eisman JA; Igarashi T (ed.), Genetics of Bone Biology and Skeletal Disease, pp. 151 - 167, http://dx.doi.org/10.1016/B978-0-12-387829-8.00011-1
,2013, 'Pharmacogenetics and pharmacogenomics of osteoporosis: Personalized medicine outlook', in Genetics of Bone Biology and Skeletal Disease, Academic Press, pp. 151 - 169
,2013, 'Preface', in Genetics of Bone Biology and Skeletal Disease, Elsevier, pp. vii - viii, http://dx.doi.org/10.1016/b978-0-12-387829-8.00040-8
,2011, 'Vitamin D and osteoporosis', in Vitamin D: Two-Volume Set, pp. 1129 - 1144, http://dx.doi.org/10.1016/B978-0-12-381978-9.10061-7
,2011, 'Chapter 61 Vitamin D and Osteoporosis', in Vitamin D, Elsevier, pp. 1129 - 1144, http://dx.doi.org/10.1016/b978-0-12-381978-9.10061-7
,2010, 'Chapter 29 Individualized Prognosis of Fracture in Men', in Osteoporosis in Men, Elsevier, pp. 361 - 373, http://dx.doi.org/10.1016/b978-0-12-374602-3.00029-8
,2009, 'Individualized Progress of Fractures in Men', in Orwoll E; Bilezikian J; Vanderschueren D (ed.), Osteoporosis in Men The Effects of Gender on Skeletal Health, Academic Press, pp. 361 - 373
,2005, 'Vitamin D Receptor Promoter and Regulation of Receptor Expression', in Vitamin D, pp. 193 - 217, http://dx.doi.org/10.1016/B978-012252687-9/50015-2
,2005, 'CHAPTER 12 Vitamin D Receptor Promoter and Regulation of Receptor Expression', in Vitamin D, Elsevier, pp. 193 - 217, http://dx.doi.org/10.1016/b978-012252687-9/50015-2
,2004, 'Vitamin D Receptor Promoter and Regulation of Receptor Expression', in Vitamin D, Second Edition, pp. 193 - 217, http://dx.doi.org/10.1016/B978-012252687-9/50015-2
,2001, 'Glucocorticoid-Induced Osteoporosis', in Osteoporosis, Elsevier, pp. 169 - 193, http://dx.doi.org/10.1016/b978-012470862-4/50045-3
,1999, 'Risk factors for low bone mass in men', in Osteoporosis in men, Academic Press, San Diego, California, pp. 335 - 361
,1999, 'Risk Factors for Low Bone Mass in Men', in Osteoporosis in Men, Elsevier, pp. 335 - 361, http://dx.doi.org/10.1016/b978-012528640-4/50018-6
,1998, 'Genes and osteoporosis', in Osteoporosis in Clinical Practice, Springer Verlag, London, UK, pp. 37 - 40
,1988, '1,25-DIHYDROXYVITAMIN D3 AND THE REGULATION OF CANCER CELL REPLICATION.', in Vitamin D, DE GRUYTER, pp. 291 - 299, http://dx.doi.org/10.1515/9783110846713.291
,1977, 'I,25-Dihydroxyvitamin D3 from Solanum Glaucophyllum', in Vitamin D - Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism, De Gruyter, pp. 29 - 32, http://dx.doi.org/10.1515/9783112327203-007
,Journal articles
2024, 'Correction: Sex-differential testosterone response to long-term weight loss (International Journal of Obesity, (2024), 10.1038/s41366-024-01591-7)', International Journal of Obesity, 48, pp. 1514, http://dx.doi.org/10.1038/s41366-024-01597-1
,2024, 'Measurement of Spiritual Wellbeing in an Australian Hospital Population Using the Functional Assessment of Chronic Illness Therapy: Spiritual Wellbeing Scale (FACIT-Sp-12)', Journal of Religion and Health, 63, pp. 3714 - 3728, http://dx.doi.org/10.1007/s10943-024-02064-x
,2024, 'Sex-differential testosterone response to long-term weight loss', International Journal of Obesity, 48, pp. 1481 - 1488, http://dx.doi.org/10.1038/s41366-024-01591-7
,2024, 'Femoral neck width and hip fracture risk', Journal of Bone and Mineral Research, 39, pp. 1201 - 1202, http://dx.doi.org/10.1093/jbmr/zjae113
,2024, 'Multimorbidity clusters potentially superior to individual diseases for stratifying fracture risk in older people: a nationwide cohort study', Age and Ageing, 53, http://dx.doi.org/10.1093/ageing/afae164
,2024, 'A meta-analysis of previous falls and subsequent fracture risk in cohort studies', Osteoporosis International, 35, pp. 469 - 494, http://dx.doi.org/10.1007/s00198-023-07012-1
,2024, 'Australian Patient Preferences for Discussing Spiritual Issues in the Hospital Setting: An Exploratory Mixed Methods Study', Journal of Religion and Health, 63, pp. 238 - 256, http://dx.doi.org/10.1007/s10943-023-01767-x
,2024, 'Response to the Letter by Yi Wang: “Reflections on ‘sex-differential testosterone response to long-term weight loss’: illuminating findings and considered limitations”', International Journal of Obesity, http://dx.doi.org/10.1038/s41366-024-01692-3
,2023, 'Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-33317-6
,2023, 'Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX', Osteoporosis International, 34, pp. 2027 - 2045, http://dx.doi.org/10.1007/s00198-023-06870-z
,2023, 'Genetic Prediction of Lifetime Risk of Fracture.', J Clin Endocrinol Metab, 108, pp. e1403 - e1412, http://dx.doi.org/10.1210/clinem/dgad254
,2023, 'Australian Patient Preferences for the Introduction of Spirituality into their Healthcare Journey: A Mixed Methods Study', Journal of Religion and Health, 62, pp. 2323 - 2340, http://dx.doi.org/10.1007/s10943-022-01616-3
,2023, 'Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review', Osteoporosis International, 34, pp. 1037 - 1053, http://dx.doi.org/10.1007/s00198-022-06657-8
,2022, 'Decreased Mortality and Subsequent Fracture Risk in Patients With a Major and Hip Fracture After the Introduction of a Fracture Liaison Service: A 3-Year Follow-Up Survey', Journal of Bone and Mineral Research, 37, pp. 2025 - 2032, http://dx.doi.org/10.1002/jbmr.4674
,2022, 'Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan', Osteoporosis International, 33, pp. 2103 - 2136, http://dx.doi.org/10.1007/s00198-022-06435-6
,2022, 'Association between incident falls and subsequent fractures in patients attending the fracture liaison service after an index fracture: a 3-year prospective observational cohort study', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-058983
,2022, 'Performance of the Garvan Fracture Risk Calculator in Individuals with Diabetes: A Registry-Based Cohort Study', Calcified Tissue International, 110, pp. 658 - 665, http://dx.doi.org/10.1007/s00223-021-00941-1
,2022, 'Timing of therapy in osteoporosis Does it matter?', Medicine Today, 23, pp. 14 - 23
,2022, 'Effects of bariatric surgery and dietary intervention on changes in insulin resistance and appetite hormones over the period of 3 years', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.81.rc5.6
,2022, 'Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect', Journal of Bone and Mineral Research, 37, pp. 1075 - 1076, http://dx.doi.org/10.1002/jbmr.4530
,2022, 'Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study', Osteoporosis International, 33, pp. 541 - 548, http://dx.doi.org/10.1007/s00198-021-06252-3
,